CC BY-NC-ND 4.0 · J Lab Physicians 2022; 14(01): 006-010
DOI: 10.1055/s-0041-1732809
Original Article

Molecular Characterization Identifies Upstream Presence of ISAba1 to OXA Carbapenemase Genes in Carbapenem-Resistant Acinetobacter baumannii

Nageswari Gandham
1   Department of Microbiology, Dr. D.Y. Patil Medical College, Hospital and Research Center (Dr. D.Y. Patil Vidyapeeth, Pune) Pimpri, Maharashtra, India
,
Neetu Gupta
1   Department of Microbiology, Dr. D.Y. Patil Medical College, Hospital and Research Center (Dr. D.Y. Patil Vidyapeeth, Pune) Pimpri, Maharashtra, India
,
Chanda Vyawahare
1   Department of Microbiology, Dr. D.Y. Patil Medical College, Hospital and Research Center (Dr. D.Y. Patil Vidyapeeth, Pune) Pimpri, Maharashtra, India
,
Shahzad Beg Mirza
1   Department of Microbiology, Dr. D.Y. Patil Medical College, Hospital and Research Center (Dr. D.Y. Patil Vidyapeeth, Pune) Pimpri, Maharashtra, India
,
Rabindra Nath Misra
1   Department of Microbiology, Dr. D.Y. Patil Medical College, Hospital and Research Center (Dr. D.Y. Patil Vidyapeeth, Pune) Pimpri, Maharashtra, India
› Author Affiliations

Abstract

Background Evaluating the expression pattern of oxacillinases (OXA) carbapenemases is essential to understand the prevalence and spread of carbapenem resistance Acinetobacter baumannii.

Objectives The aim of the study is to evaluate the presence of OXA carbapenemase genes and ISAba1 upstream to these genes in carbapenem-resistant A. baumannii clinical isolates.

Materials and MethodsA. baumannii isolated from clinical samples were phenotypically identified and antibiotics sensitivity was performed. Multiplex polymerase chain reaction (PCR) was used to detect OXA51-like gene, OXA carbapenemases genes (OXA-23-like, OXA-24-like, and OXA-58-like), and ISAba1 in carbapenem-resistant isolates.

Results Out of 55 Acinetobacter isolates, 54 were confirmed as A. baumannii by PCR. Bla OXA-23-like gene was observed in 51 isolates of A. baumannii and none of the isolates showed the presence of bla OXA-24-like and bla OXA-58-like genes. Presence of ISAba1 upstream to OXA-23-like gene, OXA-51-like gene, and both OXA-51-like/OXA-23-like genes was observed in 51, 7, and 4 A. baumannii isolates, respectively.

Conclusion The genetic pattern of carbapenem-resistant A. baumannii isolated in this study was unique, which should be factored for clinical protocols to manage infections caused by emerging resistant strains of A. baumannii.

Supplementary Material



Publication History

Article published online:
31 August 2021

© 2021. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Kollef HM, Bassetti M, Francois B. et al. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med 2017; 43 (09) 1187-1197
  • 2 Molter G, Seifert H, Mandraka F. et al. Outbreak of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: a multi-level strategic management approach. J Hosp Infect 2016; 92 (02) 194-198
  • 3 Handal R, Qunibi L, Sahouri I. et al. Characterization of carbapenem-resistant Acinetobacter baumannii strains isolated from hospitalized patients in Palestine. Int J Microbiol 2017; 2017: 8012104
  • 4 McCann E, Srinivasan A, DeRyke CA. et al. Carbapenem-nonsusceptible gram-negative pathogens in ICU and non-ICU settings in US hospitals in 2017: a multicenter study. Open Forum Infect Dis 2018; 5 (10) ofy241
  • 5 Ben-Chetrit E, Wiener-Well Y, Lesho E. et al. An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital. Crit Care 2018; 22 (01) 319
  • 6 Pagano M, Martins AF, Barth AL. Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii. Braz J Microbiol 2016; 47 (04) 785-792
  • 7 Clinical and Laboratory Standards Institute. CLSI document M100–S26, Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: CLSI; 2017
  • 8 Saha R, Jain S, Kaur IR. Metallo beta-lactamase producing pseudomonas species—a major cause of concern among hospital associated urinary tract infection. J Indian Med Assoc 2010; 108 (06) 344-348
  • 9 Magiorakos AP, Srinivasan A, Carey RB. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18 (03) 268-281
  • 10 Woodford N, Ellington MJ, Coelho JM. et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27 (04) 351-353
  • 11 Castilho SRA, Godoy CSM, Guilarde AO. et al. Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: molecular and drug susceptibility profiles. PLoS One 2017; 12 (05) 0176790
  • 12 Manchanda V, Sanchaita S, Singh N. Multidrug resistant Acinetobacter. J Glob Infect Dis 2010; 2 (03) 291-304
  • 13 Evans BA, Amyes SG. OXA β-lactamases. Clin Microbiol Rev 2014; 27 (02) 241-263
  • 14 Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P, Carattoli A. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother 2010; 54 (10) 4168-4177
  • 15 Joshi PR, Acharya M, Kakshapati T, Leungtongkam U, Thummeepak R, Sitthisak S. Co-existence of blaOXA-23 and blaNDM-1 genes of Acinetobacter baumannii isolated from Nepal: antimicrobial resistance and clinical significance. Antimicrob Resist Infect Control 2017; 6: 21
  • 16 Kumar S, Patil PP, Singhal L, Ray P, Patil PB, Gautam V. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates reveals the emergence of blaOXA-23 and blaNDM-1 encoding international clones in India. Infect Genet Evol 2019; 75: 103986
  • 17 Vijayakumar S, Gopi R, Gunasekaran P. et al. Molecular characterization of invasive carbapenem-resistant Acinetobacter baumannii from a tertiary care hospital in South India. Infect Dis Ther 2016; 5 (03) 379-387
  • 18 Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother 2010; 54 (01) 24-38
  • 19 Ji S, Chen Y, Ruan Z. et al. Prevalence of carbapenem-hydrolyzing class D β-lactamase genes in Acinetobacter spp isolates in China. Eur J Clin Microbiol Infect Dis 2014; 33 (06) 989-997
  • 20 Vijayakumar S, Mathur P, Kapil A. et al. Molecular characterization & epidemiology of carbapenem-resistant Acinetobacter baumannii collected across India. Indian J Med Res 2019; 149 (02) 240-246
  • 21 Karunasagar A, Maiti B, Shekar M, Shenoy MS, Karunasagar I. Prevalence of OXA-type carbapenemase genes and genetic heterogeneity in clinical isolates of Acinetobacter spp. from Mangalore, India. Microbiol Immunol 2011; 55 (04) 239-246
  • 22 Meshkat Z, Amini Y, Sadeghian H, Salimizand H. ISAba1/blaOXA-23-like family is the predominant cause of carbapenem resistance in Acinetobacter baumannii and Acinetobacter nosocomialis in Iran. Infect Genet Evol 2019; 71: 60-66
  • 23 Teixeira AB, Martins AF, Barin J, Hermes DM, Pitt CP, Barth AL. First report of carbapenem-resistant Acinetobacter nosocomialis isolates harboring ISAba1-blaOXA-23 genes in Latin America. J Clin Microbiol 2013; 51 (08) 2739-2741
  • 24 Grover N, Das NK, Kumar M. et al. An evaluation of antibiotic profile, molecular characterization and risk factors associated with carbapenem resistant non-fermentative gram-negative isolates in a tertiary care centre. Int J Curr Microbiol Appl Sci 2017; 6 (05) 1057-1066
  • 25 Gupta N, Gandham N, Jadhav S, Mishra RN. Isolation and identification of Acinetobacter species with special reference to antibiotic resistance. J Nat Sci Biol Med 2015; 6 (01) 159-162